AIF1 and Alzheimer disease: Iba1, GFAP, and HO-1 immunostaining were performed in order to quantify the expression pattern of HO-1 in microglia and astrocytes, respectively, in the non-demented (Figure 6A) and AD (Figure 6B) brain samples.